The Tatts Group Limited share price is falling as it rejects Macquarie Group Ltd

Tatts Group Limited (ASX:TTS) shares have plunged after its board decided that the Tabcorp Holdings Limited (ASX:TAH) merger was superior to the takeover led by Macquarie Group Ltd (ASX:MQG).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In morning trade one of the worst-performing shares has been lottery operator Tatts Group Limited (ASX: TTS) which sank lower by over 4% to $4.35.

That decline came after the company announced that its board had determined that the Pacific Consortium's takeover proposal was not superior to the proposed merger with Tabcorp Holdings Limited (ASX: TAH).

The Pacific Consortium, led by Macquarie Group Ltd (ASX: MQG), had made an offer equating to between $4.40 and $5.00 per share.

This was based on a cash offer of $3.40 per share and one share in the wagering & gaming business (it would then relist) valued at between $1.00 and $1.60 per share.

The board stated that:

"The Indicative Proposal is predicated on a number of key assumptions (see below) that are either incorrect, inconsistent with Tatts' current expectations or unknown, and Tatts is unable to assess what impact, if any, these factors might have on the terms and conditions of the Indicative Proposal."

As a result the Tatts board has said that it is unable to grant the Pacific Consortium due diligence or otherwise engage in discussions regarding the proposal.

End of the matter? Never say never, but judging by the sell-off today the market doesn't appear to expect a better offer from the consortium.

I agree with the board on this one – that as things stand the merger with Tabcorp will create greater value for shareholders. So I'm pleased to see the board take this stance.

But I wouldn't necessarily rush into buy its shares now.  At almost 24x forward earnings I think Tatts is a little on the expensive side and investors can find greater value elsewhere in the market.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »